TREatment of degeNerative and Neoplastic Diseases With Rituximab (TREND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01277172
Recruitment Status : Unknown
Verified January 2011 by Probiomed S.A. de C.V..
Recruitment status was:  Recruiting
First Posted : January 14, 2011
Last Update Posted : January 14, 2011
Information provided by:
Probiomed S.A. de C.V.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2011
  Estimated Study Completion Date : October 2011